Biochemistry
June 30, 2021
Jaapna Dhillon
Educational background Ph.D., Purdue University…
June 30, 2021
Craig Schenck
To deal with relentless environmental pressures, plants produce an arsenal of structurally diverse defensive chemicals. These sometimes-complex compounds are derived from much simpler building blocks from primary metabolic pathways. Unlike well-documented diversification of plant specialized metabolic enzymes, core metabolic pathways are highly conserved and evolutionarily constrained because they serve essential metabolic functions, which makes manipulation of these pathways difficult. The expansion and alteration of core metabolism has given rise to the evolution of structurally diverse plant specialized metabolites. However, the underlying mechanisms enabling metabolic diversity and the connections linking core to specialized metabolism are not well known. These knowledge gaps…
Dec. 11, 2020
So-Yon Park
Host-Parasitic plant interaction is a fascinating model to study Plant-Plant interaction. Park is interested in how mobile RNAs and proteins are exchanged, transferred, and functional in other organisms through the host-parasite interaction. Cuscuta (stem parasitic plant) and Phelipanche (root parasitic plant) growing on Arabidopsis, tomato, and soybean are major parasites used in Park lab. We are also interested in how small RNAs are transported and suppress target genes under drought stress in soybeans. Educational Background B.S., Dankook University, South KoreaPh.D., Seoul National University, South Korea…
Sep. 7, 2019
Lloyd W. Sumner
The research focus of the Sumner lab includes the development of cutting-edge technologies for large-scale biochemical profiling of plant metabolites (i.e. metabolomics) and integrating these with other omics data. These technologies are then applied in a symbiotic manner for plant gene discovery, gene characterization and the elucidation of mechanistic responses to external stimuli; especially related to plant specialized metabolism or plant natural products biosynthesis. Technology enables the biology and the biology drives technology development. Current technology development projects include the development of a sophisticated and integrated ensemble including UHPLC-MS-SPE-NMR for the systematic and biologically driven annotation of plant metabolomes. This…
Sep. 7, 2019
Jay J. Thelen
Educational background Ph.D. Biological Sciences, University of Missouri Courses taught Biochemistry 4272/7272: Biochemistry…
Sep. 7, 2019
Scott C. Peck
Educational background Ph.D., Michigan State University Courses taught Biochemistry 2480: Introduction to Macromolecular Structure and Function Biochemistry 8200: Principles and Research Practices in Biochemistry…
Sep. 7, 2019
Lesa J. Beamer
Educational background Ph.D., Johns Hopkins University School of Medicine Courses taught Problem-Based Learning (PBL) for 1st and 2nd year medical students Graduate Level Structural Biology for the Life Sciences…
Sep. 7, 2019
Steven R. Van Doren
Dynamic biological assemblies are strategic and fascinating. We have been exploring molecular recognition by flexible proteins and automatic tracking of changes in complex spectra and medical images. Molecular recognition by proteins with intrinsic disorder A pivotal virus-membrane interaction: Coronaviruses use a region of Spike to merge the viral envelope with the host cell membrane. We continue to be interested in the nature of the lipid interactions with this fusogenic region of Spike. Our articles reported (i) the NMR structure of the fusion peptide in a simple membrane-mimicking environment and (ii) its insertion and distortion of the simple membrane mimic via…
Sep. 6, 2019
John J. Tanner
Educational background Ph.D. Chemistry, Brown University, 1988…
Sep. 6, 2019
Michael S. Chapman
Structural Virology – Host Interactions: The US Food & Drug Administration has now approved two gene replacement therapies: Luxturna™ (2017), a treatment for congenital blindness and Zolgenesma™ (2019) for spinal muscular atrophy (SMA). 1,500 SMA infants have now been treated for this debilitating and fatal genetic disorder. These, and treatments for hemophilia and other diseases, use recombinant rAAV vectors to deliver DNA to afflicted cells. Our structure-function analyses provide a fundamental understanding of the atomic interactions key to cell entry, trafficking, and immune neutralization. These foundations are needed for the engineering of gene therapy vectors that are efficient and specific enough…